Home/PharmaCyte Biotech/Carlos A. Trujillo

CA

Carlos A. Trujillo

Chief Financial Officer

PharmaCyte Biotech

Therapeutic Areas

Oncology Metabolic Disease

PharmaCyte Biotech Pipeline

Drug	Indication	Phase
Cell-in-a-Box® + Ifosfamide	Locally Advanced Pancreatic Cancer (LAPC)	Phase 2b
Cell-in-a-Box® Insulin-Producing Cells	Type 1 & Insulin-dependent Type 2 Diabetes	Preclinical

Leadership Team at PharmaCyte Biotech

Joshua N. Silverman

Interim Chief Executive Officer, President, and Director

Dr. José Iglesias

Consulting Chief Medical Officer

Dr. Michael M. Abecassis

View full PharmaCyte Biotech profile